Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 501–600 of 1,000
Vilaça-Faria, H., Marote, A., Lages, I., Ribeiro, C., Mendes-Pinheiro, B., Domingues, A. V., Campos, J., Lanceros-Méndez, S., Salgado, A. J., & Teixeira, F. G. (2021) · Biochimie · doi:10.1016/j.biochi.2021.06.008 · Cited by 22
Exosome-mediated renal protection: Halting the progression of fibrosis
Liu, C., Li, Q., Ma, J., Lu, B., Criswell, T. L., & Zhang, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101117 · Cited by 23
“158 The first advantage is that the dosage and potency of exosomes can be evaluated in a manner similar to conventional pharmaceutical agents.”
BackgroundInfluentialAntibacterial effects of human mesenchymal stem cells and their derivatives: a systematic review
Ramos, A. C., Lomanto, M. Y. W., Vuong, C.-K., Ohneda, O., & Fukushige, M. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1430650 · Cited by 23
Sagaradze, G. D., Nimiritsky, P., Akopyan, Z. A., Макаревич, П. И., & Efimenko, A. Y. (2018) · InTech eBooks · doi:10.5772/intechopen.78605 · Cited by 19
“MSCs secrete a number of factors that are critical for the maintenance of stem cells in their niches [4, 5].”
BackgroundNatallya, F. R., Herwanto, N., Prakoeswa, C. R. S., Indramaya, D., & Rantam, F. A. (2019) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_6_17 · Cited by 19
“Stem cell secretomes alone are now being applied in areas of regenerative medicine including chronic wound therapy.[8,9] From the Clinical Department, Faculty of Medicine, Universitas Surabaya (UBAYA), 1Department of Dermato-Venereology, Faculty of Medicine, Universitas Airlangga, Dr.”
Hummitzsch, L., Zitta, K., Rusch, R., Cremer, J., Steinfath, M., Groß, J., Fändrich, F., Berndt, R., & Albrecht, M. (2019) · Stem Cells International · doi:10.1155/2019/3725863 · Cited by 19
“Several studies demonstrated that due to the hypoxic and cytotoxic microenvironment present during and after ischemia, the survival rate of transplanted cells remains extensively low within the fi rst week after transplantation [8, 26].”
Stem cell-derived exosomes: Role in the pathogenesis and treatment of atherosclerosis
Ling, H., Guo, Z., Tan, L., Cao, Q., & Song, C. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105884 · Cited by 19
Kim, S.-N., Lee, C., Nam, J., Choi, B., Chung, E., & Song, S. U. (2020) · International Journal of Stem Cells · doi:10.15283/ijsc20070 · Cited by 19
Shatrova, A. N., Burova, E., Харченко, М. В., Smirnova, I., Lyublinskaya, O. G., Nikolsky, N. N., & Borodkina, A. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116035 · Cited by 19
Tan, H.-L., Guan, X., Hu, M., Wu, J., Li, R., Wang, L.-F., Huang, H., Yu, Z., Wang, X., Xiao, Y., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02437-z · Cited by 20
“Studies showed that mesenchymal stem cells (MSCs)derived conditioned medium (CM) and exosomes contained abundant cytokines, growth factors, extracellular matrix proteins, chemokines, and nuclear acids [18].”
BackgroundStem Cell Secretome for Spinal Cord Repair: Is It More than Just a Random Baseline Set of Factors?
Pajer, K., Bellák, T., & Nógrádi, A. (2021) · Cells · doi:10.3390/cells10113214 · Cited by 22
“The common points of the lesion-induced secretomes identified in each experiment are IL-10 and MIP-1 alpha.”
BackgroundInfluentialMareschi, K., Marini, E., Niclot, A. G. S. B., Barone, M., Pinnetta, G., Adamini, A., Spadea, M., Labanca, L., Lucania, G., Ferrero, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063234 · Cited by 21
Biophysical Modulation of Mesenchymal Stem Cell Differentiation in the Context of Skeletal Repair
Hung, C. T., Racine‐Avila, J., Pellicore, M. J., & Aaron, R. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073919 · Cited by 19
Xu, J., Xi, K., Tang, J., Wang, J., Tang, Y., Wu, L., Xu, Y., Xu, Z., Chen, L., Cui, W., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202785 · Cited by 22
Singh, N., Choonara, Y. E., & Kumar, P. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.04.005 · Cited by 21
“Although, the standard platform for cell expansion is a 2D cell culture [19,20], 3D cell culture methods used to produce secretomes is rapidly gaining popularity as it most closely mimics the physiological environment of cells [21].”
Ma, Y., Jiao, Z., Liu, X., Zhang, Q., Piao, C., Xu, J., & Wang, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03109-2 · Cited by 19
“However, there were still many safety considerations for the transplantation of MSCs in the clinic, including immunocompatibility, tumorigenicity, and emboli formation [24, 25].”
BackgroundRole of secretomes in cell-free therapeutic strategies in regenerative medicine
Karimian, A., Khoshnazar, S. M., Kazemi, T., Asadi, A., & Abdolmaleki, A. (2023) · Cell and Tissue Banking · doi:10.1007/s10561-023-10073-5 · Cited by 18
“Numerous neurotrophic factors present in the conditioned media of MSCs have been shown to be beneficial in animal models of neurodegenerative disease and injury (Vizoso et al. 2017).”
InfluentialAbrishamdar, M., Jalali, M. S., & Yazdanfar, N. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06706-y · Cited by 18
“In addition to miRNAs’ involvement in PD pathophysiology, they are also being identified as a great use for PD diagnosis and treatment [63].”
BackgroundNeuro-regenerative behavior of adipose-derived stem cells in aligned collagen I hydrogels
Lewis, M., David, G., Jacobs, D., Kuczwara, P., Woessner, A. E., Kim, J.-W., Quinn, K. P., & Song, Y. H. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100762 · Cited by 18
Recent advances in exosomal non‐coding RNA‐based therapeutic approaches for photoaging
Li, K., Zhou, P., Guo, Y., Xu, T., Lin, S., Lin, S., & Ji, C. (2023) · Skin Research and Technology · doi:10.1111/srt.13463 · Cited by 19
Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications
Lee, C., Lee, M., Na, K., & Hwang, H. S. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00376 · Cited by 22
Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease
Shi, L., Chen, L., Gao, X., Sun, X., Jin, G., Yang, Y., Shao, Y., Zhu, F., & Zhou, G. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01468-1 · Cited by 22
“As a result of the diverse array of bioactive factors they contain, MSC exert various biological effects, including regenerative, proliferative, anti-apoptotic, anti-inflammatory, anti-oxidative stress, pro-angiogenic, anti-fibrotic, anti-tumor, and anti-microbial activities (Vizoso et al. 2017).”
Li, J., Liu, Y., Zhang, R., Yang, Q., Xiong, W., He, Y., & Ye, Q. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03774-5 · Cited by 21
“There is no requirement to sustain cell viability and efficiency from production to storage to delivery [133].”
BackgroundNativel, F., Renard, D., Hached, F., Pinta, P.-G., d’Arros, C., Weiss, P., Visage, C. L., Guicheux, J., Billon-Chabaud, A., & Grimandi, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071952 · Cited by 21
Al-Rifai, R., Nguyên, P., Bouland, N., Terryn, C., Kanagaratnam, L., Poitevin, G., François-Fiquet, C., Boisson‐Vidal, C., Sevestre, M., & Tournois, C. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2003-3 · Cited by 20
Mohammadi, M. R., Luong, J. C., Rodriguez, S., Cao, R., Wheeler, A., Lau, H., Li, S., Shabestari, S. K., Chadarevian, J. P., Alexander, M., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901874 · Cited by 18
Korkmaz‐Icöz, S., Zhou, P., Guo, Y., Loganathan, S., Brlecic, P., Radovits, T., Sayour, A. A., Ruppert, M., Veres, G., Karck, M., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02166-3 · Cited by 18
“studies have revealed that the long-term survival rate of implanted MSCs is relatively low [15, 16], suggesting an alternative mode of repair, including paracrine mechanisms [17].”
BackgroundPranskūnas, M., Šimoliūnas, E., Alksnė, M., Martín, V., Gomes, P. S., Puišys, A., Kaupinis, A., & Juodžbalys, G. (2021) · Materials · doi:10.3390/ma14133512 · Cited by 20
“, obtainability, scalability, increased shelf life) [15,16].”
Meng, H., Cheng, W., Wang, L., Chen, S., Teng, Y., Lu, Z., Li, Y., & Zhao, M. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10168-y · Cited by 19
“MSC‐Exos‐based Therapeutic Cardiac Regeneration Many different stem cell types have previously been explored in clinical contexts pertaining to regenerative medicine, including bone marrow mononuclear cells, bone marrow MSCs, embryonic stem cells, cardiac stem cells, and induced pluripotent stem cells [62, 63].”
BackgroundMak, C. C. H., To, K., Fekir, K., Brooks, R. A., & Khan, W. S. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-021-00815-x · Cited by 19
“TGF-β superfamily [47] and exosomes carrying miRNA [48] which are secreted for paracrine induction into their surrounding microenvironment in vivo or into the culture medium in vitro.”
BackgroundZhao, Y., Zhang, M., Lu, G., Huang, B., Wang, D., Shao, Y., & Lu, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580131 · Cited by 19
“Furthermore, we had used ASCs to repair bladder defects in a rat augmentation model and observed improved morphological regeneration and functional restoration (Zhe et al., 2016; Wang et al., 2017).”
MethodWang, C., Wu, Y., & Jiang, J. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04431-1 · Cited by 20
“MSCs differentiate into insulin-producing β-cells and secrete paracrine factors (e.g., cytokines, apoptosis-regulating proteins) that regulate apoptosis [6].”
Aghayan, A. H., Mohammadi, D., Atashi, A., & Jamalpoor, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06712-y · Cited by 25
Wang, Q., Huang, Z., Guo, J., Chen, W., Wang, M., Ming, Y., Liu, H., Huang, M., Huang, Y., Tang, Z., et al. (2025) · Biomolecules · doi:10.3390/biom15081055 · Cited by 18
“However, potential risks are associated with exosomes of mammalian origin, such as immune reactions and disease transmission [11].”
Effects of Wharton’s jelly mesenchymal stem cells-derived secretome on colon carcinoma HT-29 cells
Rezaei‐Tazangi, F., Alidadi, H., Samimi, A., Karimi, S., & Kahorsandi, L. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101413 · Cited by 21
Pelizzo, G., Silvestro, S., Avanzini, M. A., Zuccotti, G., Mazzon, E., & Calcaterra, V. (2021) · Cells · doi:10.3390/cells10123270 · Cited by 17
Kim, W., Park, E., Yoo, H. S., Park, J., Jung, Y. M., & Park, J. H. (2022) · Nanomaterials · doi:10.3390/nano12172934 · Cited by 19
“Preferably, many reports have demonstrated that paracrine factors secreted from transplanted MSCs play a crucial role in tissue repair and regeneration [41,42].”
BackgroundBioactive Scaffold Fabricated by 3D Printing for Enhancing Osteoporotic Bone Regeneration
Zhang, X., Wang, X., Lee, W., Feng, L., Wang, B., Pan, Q., Meng, X., Cao, H., Li, L., Wang, H., et al. (2022) · Bioengineering · doi:10.3390/bioengineering9100525 · Cited by 21
“On the other hand, secretome is defined as a set of secreted membrane-enclosed vesicles containing free nucleic acids and soluble proteins [23].”
BackgroundPulido-Escribano, V., Torrecillas-Baena, B., Dorado, G., Gálvez-Moreno, M. Á., Camacho-Cardeñosa, M., & Casado‐Díaz, A. (2023) · Applied Sciences · doi:10.3390/app13042702 · Cited by 20
Danev, N., Harman, R. M., de Oliveira, L. O. F., Huntimer, L., & de Walle, G. R. V. (2023) · Scientific Reports · doi:10.1038/s41598-023-39833-9 · Cited by 17
Calixto, R. D., Freitas, G. P., Souza, P. G., Ramos, J. I. R., Santos, I. C., Oliveira, F. S., Almeida, A. L. G., Rosa, A. L., & Beloti, M. M. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31115 · Cited by 18
Russo, E., Alberti, G., Corrao, S., Borlongan, C. V., Miceli, V., Conaldi, P. G., Gaudio, F. D., & Rocca, G. L. (2023) · Cells · doi:10.3390/cells12192347 · Cited by 21
“The therapeutic application of perinatal MSCs’ secretomes may present some advantages over the direct application of cells [28].”
BackgroundAuto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy
Zhang, X., Taylor, H., Valdivia, A., Dasari, R., Buckley, A., Bonacquisti, E. E., Nguyen, J., Kanchi, K., Corcoran, D. L., Herring, L. E., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.048 · Cited by 19
Bahmyari, S., Alaee, S., Khodabandeh, Z., Talaei‐Khozani, T., Dara, M., Mehdinejadiani, S., & Solati, A. (2024) · Human & Experimental Toxicology · doi:10.1177/09603271241269019 · Cited by 17
“13 The CM comprises a variety of growth factors and agents for tissue regeneration that are produced by the stem cells.”
Adenosinergic signalling in chondrogenesis and cartilage homeostasis: Friend or foe?
Pinto-Cardoso, R., Pereira-Costa, F., Faria, J., Bandarrinha, P., Bessa-Andrês, C., Correia‐de‐Sá, P., & Noronha‐Matos, J. B. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113784 · Cited by 19
Woods, N., & MacLoughlin, R. J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100922 · Cited by 18
“Although MSCs hold promise as a cell-based therapy option due to the wide range of therapeutic effects they exert, pre-clinical and clinical trials have highlighted some associated limitations, such as the high cell count doses required, complex storage requirements, and short shelf lives [19,29].”
BackgroundPotential Cell-Based and Cell-Free Therapy for Patients with COVID-19
Tan, M. I., Alfarafisa, N. M., Septiani, P., Barlian, A., Firmansyah, M., Faizal, A., Melani, L., & Nugrahapraja, H. (2022) · Cells · doi:10.3390/cells11152319 · Cited by 18
“A therapeutic application using MSC secretomes has advantages over the application using transplanted MSCs [49].”
BackgroundYiğitbilek, F., Ozdogan, E., Abrol, N., Park, W. D., Hansen, M. J., Dasari, S., Stegall, M. D., & Taner, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952262 · Cited by 18
Cho, W. J., Ahn, J., Lee, M., Choi, H., Park, S., Cha, K., Lee, S., Arai, Y., & Lee, S. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00509-6 · Cited by 18
Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges
Ma, Z., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., & Xu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043559 · Cited by 20
Sala, F. D., Longobardo, G., Lista, G., Messina, F., & Borzacchiello, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043642 · Cited by 19
“In fact, it involves a lower risk of emboli formation after intravenous infusion and lower risks of oncogenic or pathological transformation due to uncontrolled cell differentiation [23].”
BackgroundCell-Free Therapies: The Use of Cell Extracts to Mitigate Irradiation-Injured Salivary Glands
Su, X., Upadhyay, A., Tran, S. D., & Lin, Z. (2023) · Biology · doi:10.3390/biology12020305 · Cited by 21
The Angiogenic Paracrine Potential of Mesenchymal Stem Cells
Rezaie, J., Heidarzadeh, M., Hassanpour, M., Amini, H., Shokrollahi, E., Ahmadi, M., & Rahbarghazi, R. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84433 · Cited by 17
“demonstrated large-scale secretome production and release of a vast array of bioactive factors in human uterine cervical stem cells with considerable advantages over MSCs from other tissues for research and clinical application [73].”
BackgroundNatural bioactive compounds modified with mesenchymal stem cells: new hope for regenerative medicine
Wu, J., Ge, Y., Huang, W., Zhang, L., Huang, J., Huang, N., & Luo, Y. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1446537 · Cited by 17
Jiang, J., Liang, H., Ye, Y., Huang, W., Miao, J., Tan, H., Hu, Z., Tian, H., Qin, H., Zhang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61914-8 · Cited by 23
“However, clinical translationishinderedbylowpost-transplantviabilityandunpredictable differentiation 26,27 .”
Tapia-Bustos, A., Lespay‐Rebolledo, C., Vío, V., Pérez-Lobos, R., Casanova-Ortiz, E., Ezquer, F. E., Herrera‐Marschitz, M., & Morales, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063275 · Cited by 16
Zohrabi, M., Marvast, L. D., Izadi, M., Mousavi, S. A., & Aflatoonian, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.785649 · Cited by 20
“The third mechanism is the most important mechanism due to secretion of bioactive factors (Vizoso et al., 2017).”
BackgroundAo, Y.-N., Duan, J.-J., Xiong, N., Qian, N.-N., Zhang, R., Yang, L., Yu, S.-C., & Wang, F.-Y. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06555-y · Cited by 17
“Among them, mesenchymal stem cell therapy for a variety of diseases has achieved good therapeutic results [11].”
BackgroundMa, Z., Xie, W., Luo, T., Hu, Z., Hua, J., Zhou, J., Yang, T., Wang, W., Song, Z., Yu, X., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04861-1 · Cited by 16
Li, K., Li, R., Zhao, Z., Chen, F., Liu, S., & Fu, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115449 · Cited by 23
Jiang, Q., Zhao, J., Jia, Q., Wang, H., Xue, W., Ning, F., Wang, J., Wang, Y., Zhu, Z., & Tian, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914477 · Cited by 18
“EVs mirror the biological function of the maternal cells in the treatment of diseases and offer a viable alternative to cell transplantation therapy, effectively circumventing the limitations associated with abnormal differentiation, embolism, and immunocompatibility [15].”
Gil-Chinchilla, J. I., Zapata, A. G., Moraleda, J. M., & García‐Bernal, D. (2024) · Biomolecules · doi:10.3390/biom14070734 · Cited by 21
“This enhanced effect is attributed to a more sophisticated drug release system that possibly influences MSC-EVs for improved drug delivery to cancer cells [115,116].”
BackgroundBoroumand, S., Rahmani, M., Sigaroodi, F., Ganjoury, C., Parandakh, A., Bonakdar, A., Khani, M., & Soleimani, M. (2024) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35449 · Cited by 19
Hoseini, S. M., & Montazeri, F. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102709 · Cited by 18
Engineering Exosomes for CNS Disorders: Advances, Challenges, and Therapeutic Potential
Lee, E. C., Choi, D., Lee, D.-H., & Oh, J. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073137 · Cited by 18
“This means it is possible to diagnose diseases by detecting the presence or absence of specific biomolecules in exosomes or inject drugs or proteins into exosomes [7,8].”
Kim, Y., Cho, K., Lee, H., Park, M., Shin, S.-J., Park, J., Woo, S., & Ryu, K. (2020) · Cells · doi:10.3390/cells9010221 · Cited by 16
“By inducing a hypoxic condition, culturing cells in tri-dimension, or providing a mechanical stiffness, MSC secretome could be modulated [32,34].”
BackgroundSarre, C., Contreras-López, R. A., Nernpermpisooth, N., Barr�re, C., Bahraoui, S., Terraza, C., Téjédor, G., Vincent, A., Luz‐Crawford, P., Kongpol, K., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02840-0 · Cited by 16
Shieh, J.-S., Chin, Y., Chiu, H., Hsieh, Y.-Y., Cheng, H.-R., Gu, H., & Chang, F.-W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315010 · Cited by 17
“MSCs exhibit their regeneration potential in a paracrine manner through their secretome [9].”
BackgroundMoreira, A. G., Naqvi, R., Hall, K., Emukah, C., Martinez, J., Moreira, A., Dittmar, E., Zoretic, S., Evans, M., Moses, D., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01900-7 · Cited by 17
Cellular Therapy for the Treatment of Paediatric Respiratory Disease
Brennan, L. C., O’Sullivan, A., & MacLoughlin, R. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168906 · Cited by 16
“Developing secretome products is a more cost-effective process [31].”
BackgroundAlvites, R., Branquinho, M., Sousa, A. C., Lopes, B., Sousa, P., Prada, J., Pires, I. C. R., Ronchi, G., Raimondo, S., Luís, A. L., et al. (2022) · Biomolecules · doi:10.3390/biom12060818 · Cited by 19
“The use of cell-free strategies has clear advantages over the traditional method, namely ensuring a safer administration with no risks associated with the administration of cells, in addition to an easier and more practical handling and storage [22].”
BackgroundMethodRecent advances in biological membrane-based nanomaterials for cancer therapy
Shen, M., Wu, X., Zhu, M., & Yi, X. (2022) · Biomaterials Science · doi:10.1039/d2bm01044e · Cited by 15
Abdelwahab, S. A., Khamis, N. H., Rifaai, R. A., El‐Tahawy, N. F. G., & Ibrahim, R. (2023) · Microscopy and Microanalysis · doi:10.1093/micmic/ozad046 · Cited by 15
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Hype or Hope for Skeletal Muscle Anti-Frailty
Mahindran, E., Zaman, W. S. W. K., Noordin, K. B. A. A., Tan, Y.-F., & Nordin, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097833 · Cited by 17
Toward transplantation tolerance with adipose tissue-derived therapeutics
Cheng, H.-Y., Anggelia, M. R., Lin, C., & Wei, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111813 · Cited by 16
“The secretome mainly consists of soluble proteins such as growth factors and cytokines, lipid, free nucleic acids, and extracellular vesicles (EV) (52).”
BackgroundMesenchymal stem cell therapy in aqueous deficient dry eye disease
Møller‐Hansen, M. (2023) · Acta Ophthalmologica · doi:10.1111/aos.15739 · Cited by 17
“They have a remarkable ability to perceive local environmental needs and once administered, MSCs do not persist in the body for an extended period (Vizoso et al., 2017).”
BackgroundZhang, J., Chen, L., Yu, J., Tian, W., & Guo, S. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03998-5 · Cited by 18
“…differentiation of MSCs at the site of injury, but also plays an important role in paracrine action, in which bioactive substances can diffuse to neighboring cells through the intercellular space, participate in cell-to-cell communication, and affect the biological functions of tissue cells [73].”
BackgroundMinimally Invasive Cellular Therapies for Osteoarthritis Treatment
Shah, S., Otsuka, T., Bhattacharjee, M., & Laurencin, C. T. (2020) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-020-00184-w · Cited by 17
“The major controlling mechanism of stem cells in tissue regeneration is the secretion of bioactive factors which have anti-apoptotic, anti-scarring, and neovascularization effects, as well as immunomodulatory properties, collectively known as the secretome [33].”
BackgroundOxysterols and mesenchymal stem cell biology
Reichert, C. O., de Freitas, F. A., Levy, D., & Bydlowski, S. P. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2021.02.004 · Cited by 19
Biglari, N., Mehdizadeh, A., Mastanabad, M. V., Gharaeikhezri, M. H., Afrakoti, L. G. M. P., Pourbala, H., Yousefi, M., & Soltani‐Zangbar, M. S. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154541 · Cited by 15
Mesenchymal-Stromal-Cell-Conditioned Media and Their Implication for Osteochondral Regeneration
Ivanisova, D., Boháč, M., Culenova, M., Smolinská, V., & Danišovič, Ľ. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109054 · Cited by 17
“Moreover, it was also described that the applied cells could not maintain their lifespan for a long time, and, therefore, their effect needed to be provided by secreted bioactive molecules [13].”
BackgroundLange-Consiglio, A., Romele, P., Magatti, M., Silini, A. R., Idda, A., Martino, N. A., Cremonesi, F., & Parolini, O. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01611-z · Cited by 15
Yang, W. S., Kim, W. J., Ahn, J. Y., Lee, J., Ko, D. W., Park, S., Kim, J. Y., Jang, C. H., Lim, J. M., & Kim, G. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c13905 · Cited by 15
The Skin Microenvironment: A Dynamic Regulator of Hair Follicle Development, Cycling and Disease
Song, W., Peng, M., Ma, Q., Han, X., Gao, C., Zhang, W., & Liu, D. (2025) · Biomolecules · doi:10.3390/biom15091335 · Cited by 17
“Conditioned media from mesenchymal stem cells, containing proteins, lipids, free nucleic acids, and cellular vesicles, have generated widespread interest owing to their potential to induce hair regeneration, likely by promoting angiogenesis [62,63].”
Park, S. H., Jeong, Y. J., Park, S., Kim, S. Y., Kim, Y.-G., Shin, G., Jeong, H. J., Ryu, Y. B., Lee, J., Lee, O. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084403 · Cited by 14
“Regarding mammalian cell cultures, the application of CM from mesenchymal stem cells was proposed as a new therapeutic strategy in regenerative medicine, as CM effected skin wound healing and tissue repair and showed anti-apoptotic, neuroprotective, and neurotrophic effects [26,27].”
BackgroundSu, J., Ge, X., Jiang, N., Zhang, Z., & Wu, X. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220417153309 · Cited by 15
Acuto, S., Iacono, M. L., Baiamonte, E., Re, R. L., Maggio, A., & Cavalieri, V. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1273814 · Cited by 18
Emerging role of mesenchymal stromal cells in gynecologic cancer therapy
Song, Y., Liu, H., Pan, S., Xiang, X., Ye, M., & Zhu, X. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03585-0 · Cited by 16
“Recently, therapies based on cellular secretome have emerged as promising treatments for human diseases [57].”
BackgroundMeng, M., Zhang, W., Chen, S., Wang, D.-R., & Zhou, C. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i2.70 · Cited by 19
The Application of Stem Cells and Exosomes in Promoting Nerve Conduits for Peripheral Nerve Repair
Li, M., Tang, Y., Zhou, C., Geng, Y., Zhang, C., Hsu, Y.-W., Ma, L., Guo, W., Li, M., & Wang, Y. (2025) · Biomaterials Research · doi:10.34133/bmr.0160 · Cited by 15
“Notably, Salgado and colleagues [ 29 , 30 ] conducted an analysis of the factors secreted by adipose-derived stem cells (ADSCs) across various in vitro microenvironments, identifying 3 primary categories of neurotrophic factors: neurotrophic factors such as nerve growth factor (NGF), brain-derived…”
Chen, L., Zhang, J., Yu, J., Guo, S., & Tian, W. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04462-8 · Cited by 15
“Unlike periodontal ligament stem cells (PDLSCs), DFSCs possess the ability to resist and modulate the periodontal inflammatory microenvironment [5–7], which is primarily mediated through paracrine secretion [8].”
Cryopreservation of swine colostrum-derived cells
Marquez‐Curtis, L. A., Dorobantu, L. S., Sauvageau, D., & Elliott, J. A. W. (2020) · Cryobiology · doi:10.1016/j.cryobiol.2020.05.010 · Cited by 14
Reviewing the role of cardiac exosomes in myocardial repair at a glance
Koohsarian, P., Talebi, A., Rahnama, M. A., Zomorrod, M. S., Kaviani, S., & Jalili, A. (2020) · Cell Biology International · doi:10.1002/cbin.11515 · Cited by 15
“affect the condition of the pathogenic cardiac tissue, fibrosis, immunity, and cardiac stem cells proliferation within the damaged organ (Turturici et al., 2014; Vizoso et al., 2017; White et al., 2016).”
BackgroundRamalingam, M., Jang, S., & Jeong, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052322 · Cited by 14
“These factors include secreted lipids, proteins, nucleic acids, chemokines, cytokines, growth factors, hormones, and extracellular vesicles (EVs) [26,27].”
BackgroundMesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future
Beghini, D. G., Horita, S. I. M., & Henriques‐Pons, A. (2021) · Cells · doi:10.3390/cells10102588 · Cited by 16
“It was observed that secretome-based therapies improved the pathological condition after cerebral ischemia, myocardial infarction, and trauma [107].”
BackgroundHarane, S. E., Durual, S., Braschler, T. M., André‐Lévigne, D., Brembilla, N. C., Krause, K., Modarressi, A., & Preynat‐Seauve, O. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17082 · Cited by 16
Umar, A. K., Luckanagul, J. A., Zothantluanga, J. H., & Sriwidodo, S. (2022) · Pharmaceuticals · doi:10.3390/ph15070867 · Cited by 14
“Within 30 min of injection, the secretome can extend to other tissues/organs such as the lung, liver, kidney, spleen, muscle, heart, and possibly the brain [20,21].”
BackgroundBaldassarro, V. A., Perut, F., Cescatti, M., Pinto, V., Fazio, N., Alastra, G., Parziale, V., Bassotti, A., Fernández, M., Giardino, L., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03344-1 · Cited by 14
In situ injectable hydrogels for spinal cord regeneration: advances from the last 10 years
Morgado, P. I., Palacios, M., & Larraín, J. (2019) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ab52e8 · Cited by 15
Widhiyanto, L., Utomo, D. N., Perbowo, A. P., Hernugrahanto, K. D., & Purwati (2020) · Journal of Biomaterials Applications · doi:10.1177/0885328220934938 · Cited by 14
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.